Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic oncologic emergencies.

D J Glover1, J H Glick

  • 1Hematology-Oncology Section, University of Pennsylvania Cancer Center, Philadelphia.

CA: a Cancer Journal for Clinicians
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First--select the target: better choice of adjuvant treatments for breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2006
Same author

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

Annals of oncology : official journal of the European Society for Medical Oncology·2005
Same author

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.

Bone marrow transplantation·2003
Same author

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).

Cancer·2001
Same author

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).

Leukemia & lymphoma·2001
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
See all related articles

Recognizing and treating life-threatening metabolic emergencies in cancer patients is crucial. Prompt intervention improves survival and quality of life, enabling patients to complete their antitumor therapy.

Area of Science:

  • Oncology
  • Internal Medicine
  • Critical Care Medicine

Background:

  • Advances in antitumor therapies have increased patient survival, leading to a greater prevalence of metabolic complications.
  • Metabolic emergencies pose significant risks to patients undergoing cancer treatment.
  • Early identification and management are vital for patient outcomes.

Purpose of the Study:

  • To highlight the importance of recognizing and managing life-threatening metabolic emergencies in oncology.
  • To emphasize the impact of timely diagnosis and treatment on patient survival and quality of life.
  • To underscore the necessity of addressing metabolic issues to allow patients to receive definitive cancer therapy.

Main Methods:

  • This study is a review and synthesis of current knowledge on metabolic emergencies in cancer patients.

Related Experiment Videos

  • It focuses on the clinical recognition and management strategies for these critical conditions.
  • Evidence from existing literature on oncology and critical care was analyzed.

    • Main Results:

    • Metabolic emergencies are a significant concern in patients receiving antitumor therapy.
    • Prompt and accurate diagnosis can reverse these life-threatening conditions.
    • Effective management allows patients to tolerate and benefit from definitive cancer treatments.

    Conclusions:

    • Timely intervention for metabolic emergencies is essential for improving survival in oncology patients.
    • Addressing these emergencies enhances the patient's ability to undergo and complete their prescribed cancer treatment.
    • Recognition and management of metabolic emergencies are key components of comprehensive cancer care.